• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Yesterday

    10/3/22 3:24:45 AM ET
    $AAN
    $AEHL
    $AEI
    $AIMD
    Diversified Commercial Services
    Consumer Discretionary
    Building Materials
    Industrials
    Get the next $AAN alert in real time by email

    Gainers

    • FingerMotion, Inc. (NASDAQ:FNGR) gained 82.2% to close at $3.37.
    • SAI.TECH Global Corporation (NASDAQ:SAI) gained 43.4% to close at $3.24 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
    • F45 Training Holdings Inc. (NYSE:FXLV) shares gained 41.1% to close at $3.09 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares climbed 39% to close at $10.08. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
    • SOBR Safe, Inc. (NASDAQ:SOBR) gained 38.9% to close at $2.68 after the company announced it signed three reseller agreements with national distributors.
    • Ainos, Inc. (NASDAQ:AIMD) shares jumped 37% to close at $1.89 on Friday after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
    • Alset EHome International Inc. (NASDAQ:AEI) climbed 30.9% to close at $0.2562.
    • O2Micro International Limited (NASDAQ:OIIM) gained 30.2% to close at $4.23 after the company announced it entered into a definitive agreement for a "going private" transaction.
    • PolarityTE, Inc. (NASDAQ:PTE) surged 27.9% to close at $0.87.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) gained 27.8% to close at $2.30. The FDA granted 510(k) clearance to the company’s CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III.
    • VectivBio Holding AG (NASDAQ:VECT) jumped 26.1% to close at $6.00.
    • Vincerx Pharma, Inc. (NASDAQ:VINC) surged 25.5% to close at $1.38.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) gained 23.9% to settle at $3.22.
    • PLx Pharma Inc. (NASDAQ:PLXP) surged 23.7% to close at $0.65.
    • Waldencast plc (NASDAQ:WALD) rose 19.9% to close at $10.00.
    • Stabilis Solutions, Inc. (NASDAQ:SLNG) gained 19.3% to settle at $7.74.
    • Nemaura Medical Inc. (NASDAQ:NMRD) surged 18.9% to close at $2.08. Nemaura and EVERSANA recently signed a preliminary agreement for large-scale launch of Nemaura's diabetes management program in the US.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) climbed 17% to close at $22.74.
    • FG Financial Group, Inc. (NASDAQ:FGF) gained 16.6% to settle at $FG Financial Group, Inc. (FGF).
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 14.9% to close at $6.59. InMed recently reported a FY22 net loss of $33.17 per share.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) gained 14.8% to close at $1.71. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) rose 14.3% to close at $34.05. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
    • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) gained 13.7% to close at $15.96 after the company reported clinical updates from its Phase 1 Danon Disease Trial for RP-A501m which showed initial improvements across clinical, functional and biomarker endpoints. Evercore ISI raised its price target from $65 to $75.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) gained 13.5% to settle at $0.97.
    • Athersys, Inc. (NASDAQ:ATHX) gained 13.5% to close at $1.85. Athersys recently announced it entered into amended agreements to extend the exercise period of the warrants that were issued as part of a recent registered direct offering.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) surged 12.8% to close at $1.76. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
    • Innovid Corp. (NYSE:CTV) gained 12% to settle at $2.71.
    • Quanterix Corporation (NASDAQ:QTRX) jumped 11.8% to close at $11.02.
    • MoneyLion Inc. (NYSE:ML) rose 11.1% to close at $0.8926. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
    • bluebird bio, Inc. (NASDAQ:BLUE) rose 11.1% to close at $6.33. bluebird bio recently named Katherine Breedis as interim CFO.
    • Benson Hill, Inc. (NYSE:BHIL) gained 10.9% to close at $2.74 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
    • Daseke, Inc. (NASDAQ:DSKE) climbed 10.6% to close at $5.41 after the company announced a $40 million stock repurchase program.
    • MINISO Group Holding Limited (NYSE:MNSO) surged 10.2% to close at $5.49. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
    • Poshmark, Inc. (NASDAQ:POSH) jumped 9.9% to close at $15.67.
    • Immuneering Corporation (NASDAQ:IMRX) gained 9.2% to close at $14.32. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) rose 6.6% to close at $0.65 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
    • IonQ, Inc. (NYSE:IONQ) gained 6.1% to close at $5.07 after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
    • Charles River Laboratories International, Inc. (NYSE:CRL) gained 3.6% to close at $196.80 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.

     

    Losers

    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) dipped 39.9% to settle at $20.40 on Friday.
    • Aterian, Inc. (NASDAQ:ATER) fell 37.1% to close at $1.24 after the company priced a 10,526,368 share registered direct offering at $1.90 per share.
    • Edesa Biotech, Inc. (NASDAQ:EDSA) declined 34.7% to close at $0.9213. Edesa Biotech reported statistically significant mortality reductions in Phase 2 ARDS drug study.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) dropped 32.4% to close at $0.2016. AVCT announced intent to effect reverse stock split.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) shares fell 30.5% to close at $0.6256 on Friday after the company announced pricing of a $1 million registered direct offering.
    • FedNat Holding Company (NASDAQ:FNHC) dipped 27.6% to close at $0.1150.
    • 5E Advanced Materials Inc. (NASDAQ:FEAM) fell 27.6% to close at $10.16.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) dropped 24.7% to close at $0.2703 after the company priced a common stock offering of 20.1 million shares at $0.30 per share.
    • OpGen, Inc. (NASDAQ:OPGN) dipped 24% to close at $0.2862 after the company announced a $3.38 million registered direct offering.
    • Carnival Corporation (NYSE:CCL) fell 23.3% to close at $7.03 after the company reported worse-than-expected Q3 EPS and sales results.
    • Kuke Music Holding Limited (NYSE:KUKE) dropped 22.3% to close at $0.4710. Kuke Music Holding filed for mixed shelf of up to $100 million.
    • Rent-A-Center Inc (NASDAQ:RCII) fell 21.6% to close at $17.51 as the company lowered its earnings guidance for the third quarter and named Mr. Fahmi Karam as new Executive Vice President - Chief Financial Officer.
    • SHF Holdings Inc (NASDAQ:SHFS) fell 20% to close at $6.99 after declining 15% on Thursday. Northern Lights Acquisition completed business combination of SHF, Safe Harbor Financial, which offers compliance services to financial institutions that serve the regulated cannabis industry.
    • COMSovereign Holding Corp. (NASDAQ:COMS) dropped 19.9% to close at $0.0768.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 19.4% to close at $0.4799.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) dropped 19.1% to close at $4.15. Ocular Therapeutix 10%+ owner Summer Road LLC reported purchase of 150,000 at an average price of $4.59 per share in Form 4 filing on Thursday.
    • Century Aluminum Company (NASDAQ:CENX) dipped 18.3% to close at $5.28 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
    • TH International Ltd (NASDAQ:THCH) declined 18% to close at $5.98.
    • Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) dropped 18% to close at $11.36 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
    • Terran Orbital Corporation (NYSE:LLAP) fell 17.7% to settle at $1.77.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dipped 17.3% to close at $2.24.
    • Reading International, Inc. (NASDAQ:RDIB) fell 15.8% to close at $18.70.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) dropped 15.3% to close at $27.45.
    • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares fell 15% to close at $13.95 after the company announced its REVERSE Phase 3 study of obeticholic acid did not meet its primary endpoint.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 14.8% to close at $1.61.
    • Mondee Holdings, Inc. (NASDAQ:MOND) fell 14.5% to close at $7.81.
    • Airspan Networks Holdings Inc. (NASDAQ:MIMO) dropped 14% to close at $2.02.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) fell 14% to close at $0.3614.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) fell 13.2% to close at $37.90 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) dropped 13.1% to close at $1.72.
    • NIKE, Inc. (NYSE:NKE) fell 12.8% to close at $83.12. NIKE reported better-than-expected earnings and sales results for its first quarter on Thursday. However, the company reported a rise in quarter-ended inventories and revenue in the Greater China region also declined from a year ago.
    • GigaCloud Technology Inc. (NASDAQ:GCT) dipped 11.8% to close at $10.11. GigaCloud Technology reported second-quarter FY22 sales growth of 11% year-on-year to $124 million.
    • Karat Packaging Inc. (NYSE:KRT) dropped 11.4% to close at $15.99.
    • Worthington Industries, Inc. (NYSE:WOR) declined 11.3% to settle at $38.14. BMO Capital maintained Worthington Industries with a Market Perform and lowered the price target from $58 to $52.
    • HilleVax, Inc. (NASDAQ:HLVX) fell 11.2% to close at $17.09.
    • Pintec Technology Holdings Limited (NASDAQ:PT) fell 11% to close at $0.27.
    • Under Armour, Inc. (NYSE:UAA) dipped 9.8% to settle at $6.65.
    • ContextLogic Inc. (NASDAQ:WISH) fell 9.6% to close at $0.7339.
    • Li-Cycle Holdings Corp. (NYSE:LICY) dropped 9.5% to close at $5.32. Morgan Stanley maintained Li-Cycle Holdings with an Equal-Weight and lowered the price target from $8 to $7.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) dropped 9.1% to close at $6.76.
    • Belpointe PREP, LLC (NYSE:OZ) dipped 9.1% to settle at $84.45.
    • AMTD Digital Inc. (NYSE:HKD) fell 8.2% to close at $46.80.
    • The Aaron's Company, Inc. (NYSE:AAN) dropped 7.5% to settle at $9.72.
    • DICK'S Sporting Goods, Inc. (NYSE:DKS) fell 7.4% to close at $104.64. Shares of retail and apparel companies at large traded lower in sympathy with Nike, which fell after the company reported first-quarter financial results.
    • Lululemon Athletica Inc. (NASDAQ:LULU) dipped 6.9% to close at $279.56 in sympathy with Nike, which fell after the company reported first-quarter financial results.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) fell 6.8% to close at $28.15 as the stock pulled back after gaining following FDA approval of RELYVRIO for ALS..
    Get the next $AAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAN
    $AEHL
    $AEI
    $AIMD

    CompanyDatePrice TargetRatingAnalyst
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Under Armour Inc.
    $UAA
    2/10/2026$6.20Neutral → Sell
    Citigroup
    Under Armour Inc.
    $UAA
    2/9/2026$5.00 → $6.00Market Perform
    Telsey Advisory Group
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    1/20/2026$40.00 → $28.00Overweight
    Analyst
    Waldencast plc
    $WALD
    1/14/2026$2.00Buy
    Jefferies
    Nike Inc.
    $NKE
    1/8/2026Hold
    Deutsche Bank
    More analyst ratings

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Bep Special Situations Iv Llc bought $8,000,000 worth of shares (4,000,000 units at $2.00) (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/4/26 4:30:07 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    CFO Malm Joshua bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 263% to 5,175 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:48 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $AAN
    $AEHL
    $AEI
    $AIMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Norwegian Cruise Line downgraded by Analyst with a new price target

    Analyst downgraded Norwegian Cruise Line from Overweight to Neutral and set a new price target of $20.00

    2/13/26 8:29:21 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Norwegian Cruise Line downgraded by Barclays with a new price target

    Barclays downgraded Norwegian Cruise Line from Overweight to Equal Weight and set a new price target of $23.00

    2/11/26 7:50:17 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Under Armour downgraded by Citigroup with a new price target

    Citigroup downgraded Under Armour from Neutral to Sell and set a new price target of $6.20

    2/10/26 8:00:29 AM ET
    $UAA
    Apparel
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP - Global Operations Gudlaugsson Gunnar sold $2,326,300 worth of shares (43,000 units at $54.10), decreasing direct ownership by 24% to 136,393 units (SEC Form 4)

    4 - CENTURY ALUMINUM CO (0000949157) (Issuer)

    2/27/26 5:07:39 PM ET
    $CENX
    Aluminum
    Industrials

    Director Wilhelmsen Arne Alexander sold $243,570,580 worth of shares (771,607 units at $315.67) (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/27/26 5:01:55 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Director Toledano Gabrielle B sold $19,096 worth of shares (616 units at $31.00), decreasing direct ownership by 6% to 9,385 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/25/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    $AAN
    $AEHL
    $AEI
    $AIMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.

    CLARKSBURG, Md., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OpGen, Inc. (OTC:OPGN) today announced that it is changing its name to CapForce Inc., effective today. OpGen changed its name to CapForce Inc. in order to reflect the repositioning of the Company's business to the digital investment banking and financial technology sectors. The name "CapForce" represents the "Force of Capital," symbolizing the Company's conviction as a next-generation category-defining fintech-powered investment bank that harnesses the intrinsic force of capital, through capital markets as the empowerment medium, to empower global mid-sized high growth companies to grow beyond the small-cap universe and punch above their w

    2/27/26 5:30:32 PM ET
    $OPGN
    Medical Specialities
    Health Care

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    $AAN
    $AEHL
    $AEI
    $AIMD
    SEC Filings

    View All

    OpGen Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CapForce Inc. (0001293818) (Filer)

    2/27/26 5:29:02 PM ET
    $OPGN
    Medical Specialities
    Health Care

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    IonQ Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:23:08 PM ET
    $IONQ
    EDP Services
    Technology

    $AAN
    $AEHL
    $AEI
    $AIMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XOLREMDI issued to X4 PHARMACEUTICALS INC

    Submission status for X4 PHARMACEUTICALS INC's drug XOLREMDI (ORIG-1) with active ingredient MAVORIXAFOR has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218709, Application Classification: Type 1 - New Molecular Entity

    4/29/24 2:36:51 PM ET
    $XFOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 29, 2022 - FDA Approves New Treatment Option for Patients with ALS

    For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.  “This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Off

    9/29/22 5:02:14 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAN
    $AEHL
    $AEI
    $AIMD
    Financials

    Live finance-specific insights

    View All

    UPDATE: NIKE, Inc. Announces Third Quarter Fiscal 2026 Earnings and Conference Call

    To accommodate for several holidays, NIKE, Inc. (NYSE:NKE) now plans to release its third quarter fiscal 2026 financial results on Tuesday, March 31, 2026, at approximately 1:15 p.m. PT, following the close of regular stock market trading hours. Following the news release, NIKE, Inc. management will host a conference call beginning at 2:00 p.m. PT to review results. The conference call will be broadcast live over the Internet and can be accessed at https://investors.nike.com/. For those unable to listen to the live broadcast, an archived version will be available at the same location through 9:00 p.m. PT, April 23, 2026. About NIKE, Inc. NIKE, Inc., headquartered in Beaverton, Oregon,

    2/27/26 3:58:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    NIKE, Inc. Announces Third Quarter Fiscal 2026 Earnings and Conference Call

    NIKE, Inc. (NYSE:NKE) plans to release its third quarter fiscal 2026 financial results on Thursday, April 2, 2026, at approximately 1:15 p.m. PT, following the close of regular stock market trading hours. Following the news release, NIKE, Inc. management will host a conference call beginning at 2:00 p.m. PT to review results. The conference call will be broadcast live over the Internet and can be accessed at https://investors.nike.com/. For those unable to listen to the live broadcast, an archived version will be available at the same location through 9:00 p.m. PT, April 23, 2026. About NIKE, Inc. NIKE, Inc., headquartered in Beaverton, Oregon, is the world's leading designer, markete

    2/26/26 5:00:00 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    /C O R R E C T I O N -- Lindblad Expeditions Holdings, Inc./

    In the news release, Lindblad Expeditions Holdings, Inc. Reports 2025 Fourth Quarter and Full Year Financial Results, issued 26-Feb-2026 by Lindblad Expeditions Holdings, Inc. over PR Newswire, we are advised by the company that the conference call time is 9:00 a.m. Eastern Time on February 26, 2026 rather than 8:30 a.m. Eastern Time. The complete, corrected release follows: Lindblad Expeditions Holdings, Inc. Reports 2025 Fourth Quarter and Full Year Financial Results 2025 Delivered the Strongest Adjusted EBITDA Performance in Company HistoryHighlights:Total revenues increased 20% to $771.0 millionNet loss available to stockholders decreased $1.2 million to $34.6 million; including a $23.5

    2/26/26 7:30:00 AM ET
    $LIND
    Transportation Services
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Leadership Updates

    Live Leadership Updates

    View All

    Chip Wilson Provides Update to lululemon Shareholders

    VANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today released the following letter to lululemon shareholders: Shareholders of lululemon:In support of all shareholders, I am pursuing a campaign to catalyze a quantum of change that is sorely needed at lululemon. To effect that change, I have pursued private, constructive dialogues with the lululemon Board of Directors (the "Board") for the past few months. My attempts toward a sensible solution have not been reciprocated.The heart of the issue is a disconnect between the Company's creative engine and the Board's str

    2/27/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Charles River Laboratories Announces Executive Appointments

    Glenn G. Coleman Will Join Charles River as Corporate Executive Vice President and Chief Financial Officer Kerry Dailey Will Join Charles River as Corporate Senior Vice President and Chief Legal Officer Charles River Laboratories International, Inc. (NYSE:CRL) today announced two executive appointments: Glenn G. Coleman has been named the Company's next Chief Financial Officer and Kerry Dailey has been named to the newly-created position of Chief Legal Officer. Birgit Girshick, Corporate Executive Vice President, Chief Operating Officer and incoming Chief Executive Officer, commented, "We are very pleased to welcome Kerry Dailey and Glenn Coleman in two key executive roles, as we stre

    2/18/26 7:01:00 AM ET
    $CRL
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Royal Caribbean Group Appoints Christopher J. Wiernicki to Board of Directors

    MIAMI, Feb. 17, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE:RCL) today announced the appointment of Christopher J. Wiernicki, former Chairman & CEO, American Bureau of Shipping (ABS), to its Board of Directors, effective immediately. Wiernicki brings more than four decades of commercial, government and international experience in marine and offshore design, along with operations, infrastructure and safety management, ports and bunkering, digitalization, cyber security, and clean energy transition expertise.During his fourteen-year tenure at the helm of ABS, a global leader

    2/17/26 8:27:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AAN
    $AEHL
    $AEI
    $AIMD
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Stabilis Solutions Inc. on Jun 7 Indicate?

    Recently, on June 7, 2024, a notable insider purchase occurred at Stabilis Solutions Inc., as reported in a Form 4 filing by Puhala Andrew Lewis. Mr. Lewis purchased $4,150 worth of shares, acquiring 1,000 units at $4.15 per share. This transaction increased his direct ownership by 3% to 33,618 units. Insider transactions such as this one can provide valuable insights for investors, signaling confidence or positive sentiment from those within the company. Examining the historical insider transactions at Stabilis Solutions Inc., several interesting patterns emerge. In a previous Form 4 filed on May 2, 2023, Puhala Andrew Lewis initiated his ownership stake. This was followed by filings from

    6/10/24 12:45:26 AM ET
    $SLNG
    Oil/Gas Transmission
    Utilities

    $AAN
    $AEHL
    $AEI
    $AIMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Pharmaceuticals Inc.

    SC 13D/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)

    12/16/24 7:51:51 PM ET
    $RCKT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by MoneyLion Inc.

    SC 13D/A - MONEYLION INC. (0001807846) (Subject)

    12/10/24 5:27:46 PM ET
    $ML
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Li-Cycle Holdings Corp.

    SC 13D/A - Li-Cycle Holdings Corp. (0001828811) (Subject)

    12/9/24 6:03:27 PM ET
    $LICY
    Environmental Services
    Industrials